1
|
Kuznetsova JV, Tkachenko VT, Petrovskaya LM, Filkina ME, Shybanov DE, Grishin YK, Roznyatovsky VA, Tafeenko VA, Pestretsova AS, Yakovleva VA, Pokrovsky VS, Kukushkin ME, Beloglazkina EK. [3+2]-Cycloaddition of Nitrile Imines to Parabanic Acid Derivatives-An Approach to Novel Spiroimidazolidinediones. Int J Mol Sci 2023; 25:18. [PMID: 38203188 PMCID: PMC10778941 DOI: 10.3390/ijms25010018] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/28/2023] [Revised: 12/14/2023] [Accepted: 12/16/2023] [Indexed: 01/12/2024] Open
Abstract
Approximately 1,3-Dipolar cycloaddition of imidazolidine derivatives containing exocyclic double bonds is a convenient method of creating spiro-conjugated molecules with promising anticancer activity. In this work, the derivatives of parabanic acid (2-thioxoimidazolidine-4,5-diones and 5-aryliminoimidazolidine-2,4-diones) were first investigated as dipolarophiles in the reactions with nitrile imines. The generation of nitrile imines was carried out either by the addition of tertiary amine to hydrazonoyl chlorides «drop by drop» or using the recently proposed diffusion mixing technique, which led to ~5-15% increases in target compound yields. It was found that the addition of nitrile imines to C=S or C=N exocyclic double bonds led to 1,2,4-thiazolines or triazolines and occurred regioselectively in accordance with the ratio of FMO coefficients of reactants. The yield of the resulting spiro-compound depended on the presence of alkyl substituents in the nitrile imine structure and was significantly decreased in reactions with imines with strong electron donor or electron-withdrawing groups. Some of the obtained compounds showed reasonable in vitro cytotoxicity. IC50 values were calculated for HCT116 (colon cancer) cells using the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) test.
Collapse
Affiliation(s)
- Juliana V. Kuznetsova
- Department of Chemistry, M.V. Lomonosov Moscow State University, Leninskie Gory, 1-3, 119991 Moscow, Russia; (J.V.K.); (V.T.T.); (L.M.P.); (M.E.F.); (D.E.S.); (Y.K.G.); (V.A.R.); (V.A.T.); (M.E.K.)
| | - Varvara T. Tkachenko
- Department of Chemistry, M.V. Lomonosov Moscow State University, Leninskie Gory, 1-3, 119991 Moscow, Russia; (J.V.K.); (V.T.T.); (L.M.P.); (M.E.F.); (D.E.S.); (Y.K.G.); (V.A.R.); (V.A.T.); (M.E.K.)
| | - Lada M. Petrovskaya
- Department of Chemistry, M.V. Lomonosov Moscow State University, Leninskie Gory, 1-3, 119991 Moscow, Russia; (J.V.K.); (V.T.T.); (L.M.P.); (M.E.F.); (D.E.S.); (Y.K.G.); (V.A.R.); (V.A.T.); (M.E.K.)
| | - Maria E. Filkina
- Department of Chemistry, M.V. Lomonosov Moscow State University, Leninskie Gory, 1-3, 119991 Moscow, Russia; (J.V.K.); (V.T.T.); (L.M.P.); (M.E.F.); (D.E.S.); (Y.K.G.); (V.A.R.); (V.A.T.); (M.E.K.)
| | - Dmitry E. Shybanov
- Department of Chemistry, M.V. Lomonosov Moscow State University, Leninskie Gory, 1-3, 119991 Moscow, Russia; (J.V.K.); (V.T.T.); (L.M.P.); (M.E.F.); (D.E.S.); (Y.K.G.); (V.A.R.); (V.A.T.); (M.E.K.)
| | - Yuri K. Grishin
- Department of Chemistry, M.V. Lomonosov Moscow State University, Leninskie Gory, 1-3, 119991 Moscow, Russia; (J.V.K.); (V.T.T.); (L.M.P.); (M.E.F.); (D.E.S.); (Y.K.G.); (V.A.R.); (V.A.T.); (M.E.K.)
| | - Vitaly A. Roznyatovsky
- Department of Chemistry, M.V. Lomonosov Moscow State University, Leninskie Gory, 1-3, 119991 Moscow, Russia; (J.V.K.); (V.T.T.); (L.M.P.); (M.E.F.); (D.E.S.); (Y.K.G.); (V.A.R.); (V.A.T.); (M.E.K.)
| | - Viktor A. Tafeenko
- Department of Chemistry, M.V. Lomonosov Moscow State University, Leninskie Gory, 1-3, 119991 Moscow, Russia; (J.V.K.); (V.T.T.); (L.M.P.); (M.E.F.); (D.E.S.); (Y.K.G.); (V.A.R.); (V.A.T.); (M.E.K.)
| | - Anna S. Pestretsova
- Blokhin National Medical Research Center of Oncology, Ministry of Health of the Russian Federation, 115478 Moscow, Russia; (A.S.P.); (V.S.P.)
- Occupational Health Risks Lab, Peoples’ Friendship University of Russia (RUDN University), 117198 Moscow, Russia
| | - Vera A. Yakovleva
- Department of Biochemistry, People’s Friendship University of Russia (RUDN University), 117198 Moscow, Russia;
| | - Vadim S. Pokrovsky
- Blokhin National Medical Research Center of Oncology, Ministry of Health of the Russian Federation, 115478 Moscow, Russia; (A.S.P.); (V.S.P.)
- Department of Biochemistry, People’s Friendship University of Russia (RUDN University), 117198 Moscow, Russia;
- Research Institute of Molecular and Cellular Medicine, People’s Friendship University of Russia (RUDN University), 117198 Moscow, Russia
| | - Maxim E. Kukushkin
- Department of Chemistry, M.V. Lomonosov Moscow State University, Leninskie Gory, 1-3, 119991 Moscow, Russia; (J.V.K.); (V.T.T.); (L.M.P.); (M.E.F.); (D.E.S.); (Y.K.G.); (V.A.R.); (V.A.T.); (M.E.K.)
| | - Elena K. Beloglazkina
- Department of Chemistry, M.V. Lomonosov Moscow State University, Leninskie Gory, 1-3, 119991 Moscow, Russia; (J.V.K.); (V.T.T.); (L.M.P.); (M.E.F.); (D.E.S.); (Y.K.G.); (V.A.R.); (V.A.T.); (M.E.K.)
| |
Collapse
|
2
|
Alshammari MB, Aly AA, Ahmad A, Brown AB, Mohamed AH. Recent synthetic strategies of spiro-azetidin-2-one, -pyrrolidine, -indol(one) and -pyran derivatives-a review. RSC Adv 2023; 13:32786-32823. [PMID: 37942448 PMCID: PMC10628897 DOI: 10.1039/d3ra06054c] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/05/2023] [Accepted: 10/24/2023] [Indexed: 11/10/2023] Open
Abstract
Spiro-heterocycles have received special attention in medicinal chemistry because of their promising biological activity. Over the years, many synthetic methodologies have been established for the construction of spirocyclic compounds. Spiro heterocycles such as spiro-azetidin-2-one, -pyrrolidine, -indol(one) and -pyran derivatives have been found to exhibit diversified biological and pharmacological activity in addition to their therapeutic properties. In view of these facts, we decided in this review to present representative synthetic approaches of the aforementioned spiro heterocycles, especially in the past 20 years.
Collapse
Affiliation(s)
- Mohammed B Alshammari
- Chemistry Department, College of Sciences and Humanities, Prince Sattam Bin Abdulaziz University Al-Kharij Saudi Arabia
| | - Ashraf A Aly
- Chemistry Department, Faculty of Science, Minia University 61519 El-Minia Egypt
| | - Akil Ahmad
- Chemistry Department, College of Sciences and Humanities, Prince Sattam Bin Abdulaziz University Al-Kharij Saudi Arabia
| | - Alan B Brown
- Department of Chemistry and Chemical Engineering, Florida Institute of Technology Melbourne FL 32901 USA
| | - Asmaa H Mohamed
- Chemistry Department, Faculty of Science, Minia University 61519 El-Minia Egypt
| |
Collapse
|
3
|
Filkina ME, Baray DN, Beloglazkina EK, Grishin YK, Roznyatovsky VA, Kukushkin ME. Regioselective Cycloaddition of Nitrile Imines to 5-Methylidene-3-phenyl-hydantoin: Synthesis and DFT Calculations. Int J Mol Sci 2023; 24:ijms24021289. [PMID: 36674803 PMCID: PMC9864863 DOI: 10.3390/ijms24021289] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2022] [Revised: 01/04/2023] [Accepted: 01/07/2023] [Indexed: 01/11/2023] Open
Abstract
Nitrile imine cycloaddition to hydantoins containing an exocyclic C=C double bond has been previously described in a very limited number of examples. In this work, regioselective synthesis of spiro-pyrazoline-imidazolidine-2,4-diones based on a 1,3-dipolar cycloaddition reaction of nitrile imines to 5-methylidene-3-phenyl-hydantoin have been proposed. It was found that, regardless of the nature of the aryl substituents at the terminal C and N atoms of the C-N-N fragment of nitrile imine (electron donor or electron acceptor), cycloaddition to the 5-methylidenhydantoin exocyclic C=C bond proceeds regioselectively, and the terminal nitrogen atom of the nitrile imine connects to the more sterically hindered carbon atom of the double bond, which leads to the formation of a 5-disubstituted pyrazoline ring. The observed cycloaddition regioselectivity was rationalized using DFT calculations of frontier molecular orbital interactions, global CDFT reactivity indices, and minimum energy paths.
Collapse
|
4
|
Filatov VE, Iuzabchuk DA, Tarasevich BN, Zyk NV, Beloglazkina EK. A convenient -diastereoselective synthesisof -isatin arylimines the aza-Wittig reaction. MENDELEEV COMMUNICATIONS 2022. [DOI: 10.1016/j.mencom.2022.09.022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
5
|
Filatov VE, Iuzabchuk DA, Tafeenko VA, Grishin YK, Roznyatovsky VA, Lukianov DA, Fedotova YA, Sukonnikov MA, Skvortsov DA, Zyk NV, Beloglazkina EK. Dispirooxindole-β-Lactams: Synthesis via Staudinger Ketene-Imine Cycloaddition and Biological Evaluation. Int J Mol Sci 2022; 23:ijms23126666. [PMID: 35743110 PMCID: PMC9223813 DOI: 10.3390/ijms23126666] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/17/2022] [Revised: 06/05/2022] [Accepted: 06/14/2022] [Indexed: 11/17/2022] Open
Abstract
In this work, we present the first synthesis of dispirooxindole-β-lactams employing optimized methodology of one-pot Staudinger ketene-imine cycloaddition with N-aryl-2-oxo-pyrrolidine-3-carboxylic acids as the ketene source. Spiroconjugation of indoline-2-one with β-lactams ring is considered to be able to provide stabilization and wide scope of functionalization to resulting scaffolds. The dispipooxindoles obtained demonstrated medium cytotoxicity in the MTT test on A549, MCF7, HEK293, and VA13 cell lines, and one of the compounds demonstrated antibacterial activity against E. coli strain LPTD.
Collapse
Affiliation(s)
- Vadim E. Filatov
- Department of Chemistry, Lomonosov Moscow State University, Leninskie Gory 1-3, 119234 Moscow, Russia; (V.E.F.); (D.A.I.); (V.A.T.); (Y.K.G.); (V.A.R.); (D.A.L.); (Y.A.F.); (M.A.S.); (D.A.S.); (N.V.Z.)
| | - Dmitrii A. Iuzabchuk
- Department of Chemistry, Lomonosov Moscow State University, Leninskie Gory 1-3, 119234 Moscow, Russia; (V.E.F.); (D.A.I.); (V.A.T.); (Y.K.G.); (V.A.R.); (D.A.L.); (Y.A.F.); (M.A.S.); (D.A.S.); (N.V.Z.)
| | - Viktor A. Tafeenko
- Department of Chemistry, Lomonosov Moscow State University, Leninskie Gory 1-3, 119234 Moscow, Russia; (V.E.F.); (D.A.I.); (V.A.T.); (Y.K.G.); (V.A.R.); (D.A.L.); (Y.A.F.); (M.A.S.); (D.A.S.); (N.V.Z.)
| | - Yuri K. Grishin
- Department of Chemistry, Lomonosov Moscow State University, Leninskie Gory 1-3, 119234 Moscow, Russia; (V.E.F.); (D.A.I.); (V.A.T.); (Y.K.G.); (V.A.R.); (D.A.L.); (Y.A.F.); (M.A.S.); (D.A.S.); (N.V.Z.)
| | - Vitaly A. Roznyatovsky
- Department of Chemistry, Lomonosov Moscow State University, Leninskie Gory 1-3, 119234 Moscow, Russia; (V.E.F.); (D.A.I.); (V.A.T.); (Y.K.G.); (V.A.R.); (D.A.L.); (Y.A.F.); (M.A.S.); (D.A.S.); (N.V.Z.)
| | - Dmitrii A. Lukianov
- Department of Chemistry, Lomonosov Moscow State University, Leninskie Gory 1-3, 119234 Moscow, Russia; (V.E.F.); (D.A.I.); (V.A.T.); (Y.K.G.); (V.A.R.); (D.A.L.); (Y.A.F.); (M.A.S.); (D.A.S.); (N.V.Z.)
- Center of Life Sciences, Skolkovo Institute of Science and Technology, 143028 Skolkovo, Russia
| | - Yulia A. Fedotova
- Department of Chemistry, Lomonosov Moscow State University, Leninskie Gory 1-3, 119234 Moscow, Russia; (V.E.F.); (D.A.I.); (V.A.T.); (Y.K.G.); (V.A.R.); (D.A.L.); (Y.A.F.); (M.A.S.); (D.A.S.); (N.V.Z.)
| | - Maxim A. Sukonnikov
- Department of Chemistry, Lomonosov Moscow State University, Leninskie Gory 1-3, 119234 Moscow, Russia; (V.E.F.); (D.A.I.); (V.A.T.); (Y.K.G.); (V.A.R.); (D.A.L.); (Y.A.F.); (M.A.S.); (D.A.S.); (N.V.Z.)
| | - Dmitry A. Skvortsov
- Department of Chemistry, Lomonosov Moscow State University, Leninskie Gory 1-3, 119234 Moscow, Russia; (V.E.F.); (D.A.I.); (V.A.T.); (Y.K.G.); (V.A.R.); (D.A.L.); (Y.A.F.); (M.A.S.); (D.A.S.); (N.V.Z.)
| | - Nikolai V. Zyk
- Department of Chemistry, Lomonosov Moscow State University, Leninskie Gory 1-3, 119234 Moscow, Russia; (V.E.F.); (D.A.I.); (V.A.T.); (Y.K.G.); (V.A.R.); (D.A.L.); (Y.A.F.); (M.A.S.); (D.A.S.); (N.V.Z.)
| | - Elena K. Beloglazkina
- Department of Chemistry, Lomonosov Moscow State University, Leninskie Gory 1-3, 119234 Moscow, Russia; (V.E.F.); (D.A.I.); (V.A.T.); (Y.K.G.); (V.A.R.); (D.A.L.); (Y.A.F.); (M.A.S.); (D.A.S.); (N.V.Z.)
- Correspondence:
| |
Collapse
|
6
|
Liao M, Qin R, Huang W, Zhu HP, Peng F, Han B, Liu B. Targeting regulated cell death (RCD) with small-molecule compounds in triple-negative breast cancer: a revisited perspective from molecular mechanisms to targeted therapies. J Hematol Oncol 2022; 15:44. [PMID: 35414025 PMCID: PMC9006445 DOI: 10.1186/s13045-022-01260-0] [Citation(s) in RCA: 46] [Impact Index Per Article: 23.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/10/2022] [Accepted: 03/28/2022] [Indexed: 02/08/2023] Open
Abstract
Triple-negative breast cancer (TNBC) is a subtype of human breast cancer with one of the worst prognoses, with no targeted therapeutic strategies currently available. Regulated cell death (RCD), also known as programmed cell death (PCD), has been widely reported to have numerous links to the progression and therapy of many types of human cancer. Of note, RCD can be divided into numerous different subroutines, including autophagy-dependent cell death, apoptosis, mitotic catastrophe, necroptosis, ferroptosis, pyroptosis and anoikis. More recently, targeting the subroutines of RCD with small-molecule compounds has been emerging as a promising therapeutic strategy, which has rapidly progressed in the treatment of TNBC. Therefore, in this review, we focus on summarizing the molecular mechanisms of the above-mentioned seven major RCD subroutines related to TNBC and the latest progress of small-molecule compounds targeting different RCD subroutines. Moreover, we further discuss the combined strategies of one drug (e.g., narciclasine) or more drugs (e.g., torin-1 combined with chloroquine) to achieve the therapeutic potential on TNBC by regulating RCD subroutines. More importantly, we demonstrate several small-molecule compounds (e.g., ONC201 and NCT03733119) by targeting the subroutines of RCD in TNBC clinical trials. Taken together, these findings will provide a clue on illuminating more actionable low-hanging-fruit druggable targets and candidate small-molecule drugs for potential RCD-related TNBC therapies.
Collapse
Affiliation(s)
- Minru Liao
- State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, and West China School of Pharmacy, Sichuan University, Chengdu, 610041, China
| | - Rui Qin
- State Key Laboratory of Southwestern Chinese Medicine Resources, Hospital of Chengdu University of Traditional Chinese Medicine, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China
| | - Wei Huang
- State Key Laboratory of Southwestern Chinese Medicine Resources, Hospital of Chengdu University of Traditional Chinese Medicine, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China
| | - Hong-Ping Zhu
- State Key Laboratory of Southwestern Chinese Medicine Resources, Hospital of Chengdu University of Traditional Chinese Medicine, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China.,Antibiotics Research and Re-Evaluation Key Laboratory of Sichuan Province, Sichuan Industrial Institute of Antibiotics, Chengdu University, Chengdu, China
| | - Fu Peng
- State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, and West China School of Pharmacy, Sichuan University, Chengdu, 610041, China.
| | - Bo Han
- State Key Laboratory of Southwestern Chinese Medicine Resources, Hospital of Chengdu University of Traditional Chinese Medicine, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China.
| | - Bo Liu
- State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, and West China School of Pharmacy, Sichuan University, Chengdu, 610041, China.
| |
Collapse
|
7
|
Lopes EA, Mestre R, Fontinha D, Legac J, Pei JV, Sanches-Vaz M, Mori M, Lehane AM, Rosenthal PJ, Prudêncio M, Santos MM. Discovery of spirooxadiazoline oxindoles with dual-stage antimalarial activity. Eur J Med Chem 2022; 236:114324. [DOI: 10.1016/j.ejmech.2022.114324] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/17/2021] [Revised: 03/24/2022] [Accepted: 03/25/2022] [Indexed: 12/21/2022]
|
8
|
Zhao X, Zhou Y, Li BL, Du G, Yu Z. Highly diastereoselective cascade dearomatization of 3-(2-isocyanoethyl)indoles with nitrile imines: a facile access to unexpected polycyclic indolines. Org Chem Front 2022. [DOI: 10.1039/d1qo01731d] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
A novel cascade annulation between 2-isocyanoethylindoles and hydrazonyl chlorides has been realized to assemble a variety of unexpected polycyclic indoline derivatives with excellent diastereoselectivities under simple reaction conditions.
Collapse
Affiliation(s)
- Xiaohu Zhao
- Key Laboratory of Green Chemistry & Technology, Ministry of Education, College of Chemistry, Sichuan University, Chengdu 610064, China
| | - Yuqiao Zhou
- Key Laboratory of Green Chemistry & Technology, Ministry of Education, College of Chemistry, Sichuan University, Chengdu 610064, China
| | - Bao-Lin Li
- Key Laboratory of Green Chemistry & Technology, Ministry of Education, College of Chemistry, Sichuan University, Chengdu 610064, China
| | - Guangxi Du
- Key Laboratory of Green Chemistry & Technology, Ministry of Education, College of Chemistry, Sichuan University, Chengdu 610064, China
| | - Zhipeng Yu
- Key Laboratory of Green Chemistry & Technology, Ministry of Education, College of Chemistry, Sichuan University, Chengdu 610064, China
| |
Collapse
|
9
|
Synthesis, biological evaluation, molecular docking and in silico ADMET screening studies of novel isoxazoline derivatives from acridone. ARAB J CHEM 2021. [DOI: 10.1016/j.arabjc.2021.103057] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
10
|
Molteni G, Silvani A. Spiro‐2‐oxindoles
via
1,3‐dipolar cycloadditions. A decade update. European J Org Chem 2021. [DOI: 10.1002/ejoc.202100121] [Citation(s) in RCA: 13] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Affiliation(s)
- Giorgio Molteni
- Dipartimento di Chimica Università degli Studi di Milano Via Golgi 19 20133 Milan Italy
| | - Alessandra Silvani
- Dipartimento di Chimica Università degli Studi di Milano Via Golgi 19 20133 Milan Italy
| |
Collapse
|
11
|
Bora D, Kaushal A, Shankaraiah N. Anticancer potential of spirocompounds in medicinal chemistry: A pentennial expedition. Eur J Med Chem 2021; 215:113263. [PMID: 33601313 DOI: 10.1016/j.ejmech.2021.113263] [Citation(s) in RCA: 42] [Impact Index Per Article: 14.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/18/2020] [Revised: 01/11/2021] [Accepted: 02/01/2021] [Indexed: 12/30/2022]
Abstract
Spirocompounds constitute an important class of organic frameworks enveloping numerous pharmacological activities, among them, the promising anticancer potential of spirocompounds have enthused medicinal chemists to explore new spiro derivatives with significantly improved pharmacodynamic and pharmacokinetic profile along with their mechanism of action. The current review intends to provide a sketch of the anticancer activity of various spirocompounds like spirooxindole, spiroisoxazole, spiroindole etc, from the past five years unfolding various aspects of pharmacological activities and their structure-activity relationships (SARs). This literature analysis may provide future direction for the efficient design of novel spiromolecules with enhanced safety and efficacy.
Collapse
Affiliation(s)
- Darshana Bora
- Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, 500037, India
| | - Anjali Kaushal
- Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, 500037, India
| | - Nagula Shankaraiah
- Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, 500037, India.
| |
Collapse
|
12
|
Zhou LM, Qu RY, Yang GF. An overview of spirooxindole as a promising scaffold for novel drug discovery. Expert Opin Drug Discov 2020; 15:603-625. [PMID: 32106717 DOI: 10.1080/17460441.2020.1733526] [Citation(s) in RCA: 120] [Impact Index Per Article: 30.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
Abstract
Introduction: Spirooxindole, a unique and versatile scaffold, has been widely studied in some fields such as pharmaceutical chemistry and synthetic chemistry. Especially in the application of medicine, quite a few compounds featuring spirooxindole motif have displayed excellent and broad pharmacological activities. Many identified candidate molecules have been used in clinical trials, showing promising prospects.Areas covered: This article offers an overview of different applications and developments of spirooxindoles (including the related natural products and their derivatives) in the process of drug innovation, including such as in anticancer, antimicrobial, anti-inflammatory, analgesic, antioxidant, antimalarial, and antiviral activities. Furthermore, the crucial structure-activity relationships, molecular mechanisms, pharmacokinetic properties, and main synthetic methods of spirooxindoles-based derivatives are also reviewed.Expert opinion: Recent progress in the biological activity profiles of spirooxindole derivatives have demonstrated their significant position in present-day drug discovery. Furthermore, we believe that the multidirectional development of novel drugs containing this core scaffold will continue to be the research hotspot in medicinal chemistry in the future.
Collapse
Affiliation(s)
- Li-Ming Zhou
- Key Laboratory of Pesticide & Chemical Biology of Ministry of Education, International Joint Research Center for Intelligent Biosensor Technology and Health, College of Chemistry, Central China Normal University, Wuhan, P. R. China
| | - Ren-Yu Qu
- Key Laboratory of Pesticide & Chemical Biology of Ministry of Education, International Joint Research Center for Intelligent Biosensor Technology and Health, College of Chemistry, Central China Normal University, Wuhan, P. R. China
| | - Guang-Fu Yang
- Key Laboratory of Pesticide & Chemical Biology of Ministry of Education, International Joint Research Center for Intelligent Biosensor Technology and Health, College of Chemistry, Central China Normal University, Wuhan, P. R. China
| |
Collapse
|
13
|
Filatov V, Kukushkin M, Kuznetsova J, Skvortsov D, Tafeenko V, Zyk N, Majouga A, Beloglazkina E. Synthesis of 1,3-diaryl-spiro[azetidine-2,3′-indoline]-2′,4-dionesviathe Staudinger reaction:cis- ortrans-diastereoselectivity with different addition modes. RSC Adv 2020; 10:14122-14133. [PMID: 35498462 PMCID: PMC9051608 DOI: 10.1039/d0ra02374d] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/14/2020] [Accepted: 03/30/2020] [Indexed: 01/31/2023] Open
Abstract
A new synthetic approach for realizing biologically relevant bis-aryl spiro[azetidine-2,3′-indoline]-2′,4-diones was developed based on Staudinger ketene–imine cycloaddition through the one-pot reaction of substituted acetic acids and Schiff bases in the presence of oxalyl chloride and an organic base. A series of [azetidine-2,3′-indoline]-2′,4-diones were synthesized using this method. For comparison, the same compounds were obtained using a known technique, where ketene is generated from pre-synthesized acyl chloride. It was shown that the use of oxalyl chloride for ketene generation in the one-pot reaction at room temperature allows for the reversal of the diastereoselectivity of spiro-lactam formation, unlike previously described procedures. Two experimental techniques of the ketene–imine Staudinger reaction allowed different diastereomers of spiro-indolinone-β-lactams to be obtained.![]()
Collapse
Affiliation(s)
- Vadim Filatov
- Moscow State University
- Department of Chemistry
- Moscow 119991
- Russia
| | - Maksim Kukushkin
- Moscow State University
- Department of Chemistry
- Moscow 119991
- Russia
| | | | - Dmitry Skvortsov
- Moscow State University
- Department of Chemistry
- Moscow 119991
- Russia
- Skolkovo Institute of Science and Technology
| | - Viktor Tafeenko
- Moscow State University
- Department of Chemistry
- Moscow 119991
- Russia
| | - Nikolay Zyk
- Moscow State University
- Department of Chemistry
- Moscow 119991
- Russia
| | - Alexander Majouga
- Moscow State University
- Department of Chemistry
- Moscow 119991
- Russia
- National University of Science and Technology “MISiS”
| | | |
Collapse
|
14
|
Mayank, Kaur N, Singh N. Structural insights and influence of V599 mutations on the overall dynamics of BRAF protein against its kinase domains. Integr Biol (Camb) 2019; 10:646-657. [PMID: 30229251 DOI: 10.1039/c8ib00095f] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Mutations in the BRAF gene are well known for their oncogenic effects. Point mutations in V599 are particularly oncogenic and are considered important for therapeutic purposes. Along with wild type, other V599 mutated BRAF variants viz. V599E, V599D and V599R are reported and crystals of the former two with inhibitor (BAY43-9006) are further detailed. Both wild-type and mutated BRAF forms show similar interaction patterns with BAY43-9006, but the 599th residue did not show any involvement in the interactions. Upon BAY43-9006 binding, kinase domains of both forms were found adopting essentially identical conformations. However, BAY43-9006 shows a varied activity profile in the case of the wild and V599E variant of the BRAF protein. Furthermore, MMGBSA binding energy results for all four BRAF variants, further revealed the importance of the 599th residue. In-depth analysis viz. molecular dynamics, residue correlation studies and residue interaction network (RIN) analyses were conducted, providing a deep insight into the 599th residue and its impact on the overall dynamics of BRAF protein. Our findings reveal that the mutated residue at the 599th position not only changed the BAY43-9006-BRAF binding behaviour but also produced a massive impact on the overall dynamic behaviour of the protein. The insights obtained herein could be of great relevance for designing new BRAF inhibitors aimed at getting ideal activity against all BRAF forms.
Collapse
Affiliation(s)
- Mayank
- Department of Chemistry, Indian Institute of Technology Ropar, Punjab 140001, India.
| | - Navneet Kaur
- Department of Chemistry, Punjab University Chandigarh, Punjab, India.
| | - Narinder Singh
- Department of Chemistry, Indian Institute of Technology Ropar, Punjab 140001, India.
| |
Collapse
|
15
|
Akaev AA, Bezzubov SI, Desyatkin VG, Vorobyeva NS, Majouga AG, Melnikov MY, Budynina EM. Stereocontrolled [3+2] Cycloaddition of Donor-Acceptor Cyclopropanes to Iminooxindoles: Access to Spiro[oxindole-3,2'-pyrrolidines]. J Org Chem 2019; 84:3340-3356. [PMID: 30735387 DOI: 10.1021/acs.joc.8b03208] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
A novel stereocontrolled assembly of spiro[oxindole-3,2'-pyrrolidines] via [3+2]-cycloaddition of donor-acceptor cyclopropanes to electron-poor ketimines, iminooxindoles, was developed. The method allows for efficient employment of common readily available donor-acceptor cyclopropanes, functionalized with ester, keto, nitro, cyano etc. groups, and N-unprotected iminooxindoles. The stereospecificity of the initial SN2-like imine attack on a cyclopropane molecule together with a high diastereoselectivity of further C-C bond formation facilitate a rapid access to spiro[oxindole-3,2'-pyrrolidines] in their optically active forms. Preliminary in vitro testing of the synthesized compounds against LNCaP (p53+) and PC-3 (p53-) cells revealed good antiproliferative activities and p53-selectivity indices for several compounds that are intriguing in terms of their further investigation as inhibitors of MDM2-p53 interaction.
Collapse
Affiliation(s)
- Andrey A Akaev
- Department of Chemistry , Lomonosov Moscow State University , Leninskie Gory 1-3 , Moscow 119991 , Russia
| | - Stanislav I Bezzubov
- Kurnakov Institute of General and Inorganic Chemistry, Russian Academy of Sciences , Leninskiy pr. 31 , Moscow 119991 , Russia
| | - Victor G Desyatkin
- Department of Chemistry , Lomonosov Moscow State University , Leninskie Gory 1-3 , Moscow 119991 , Russia
| | - Nataliya S Vorobyeva
- National University of Science and Technology "MISiS" , Leninskiy pr. 4 , Moscow 119991 , Russia
| | - Alexander G Majouga
- Department of Chemistry , Lomonosov Moscow State University , Leninskie Gory 1-3 , Moscow 119991 , Russia.,National University of Science and Technology "MISiS" , Leninskiy pr. 4 , Moscow 119991 , Russia.,Dmitry Mendeleev University of Chemical Technology of Russia , Miusskaya sq. 9 , Moscow 125047 , Russia
| | - Mikhail Ya Melnikov
- Department of Chemistry , Lomonosov Moscow State University , Leninskie Gory 1-3 , Moscow 119991 , Russia
| | - Ekaterina M Budynina
- Department of Chemistry , Lomonosov Moscow State University , Leninskie Gory 1-3 , Moscow 119991 , Russia
| |
Collapse
|
16
|
Amaral JD, Silva D, Rodrigues CMP, Solá S, Santos MMM. A Novel Small Molecule p53 Stabilizer for Brain Cell Differentiation. Front Chem 2019; 7:15. [PMID: 30766866 PMCID: PMC6365904 DOI: 10.3389/fchem.2019.00015] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/12/2018] [Accepted: 01/08/2019] [Indexed: 12/17/2022] Open
Abstract
Brain tumor, as any type of cancer, is assumed to be sustained by a small subpopulation of stem-like cells with distinctive properties that allow them to survive conventional therapies and drive tumor recurrence. Thus, the identification of new molecules capable of controlling stemness properties may be key in developing effective therapeutic strategies for cancer by inducing stem-like cells differentiation. Spiropyrazoline oxindoles have previously been shown to induce apoptosis and cell cycle arrest, as well as upregulate p53 steady-state levels, while decreasing its main inhibitor MDM2 in the HCT116 human colorectal carcinoma cell line. In this study, we made modifications in this scaffold by including combinations of different substituents in the pyrazoline ring in order to obtain novel small molecules that could modulate p53 activity and act as differentiation inducer agents. The antiproliferative activity of the synthesized compounds was assessed using the isogenic pair of HCT116 cell lines differing in the presence or absence of the p53 gene. Among the tested spirooxindoles, spiropyrazoline oxindole 1a was selective against the cancer cell line expressing wild-type p53 and presented low cytotoxicity. This small molecule induced neural stem cell (NSC) differentiation through reduced SOX2 (marker of multipotency) and increased βIII-tubulin (marker of neural differentiation) which suggests a great potential as a non-toxic inducer of cell differentiation. More importantly, in glioma cancer cells (GL-261), compound 1a reduced stemness, by decreasing SOX2 protein levels, while also promoting chemotherapy sensitization. These results highlight the potential of p53 modulators for brain cell differentiation, with spirooxindole 1a representing a promising lead molecule for the development of new brain antitumor drugs.
Collapse
Affiliation(s)
- Joana D Amaral
- Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal
| | - Dário Silva
- Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal
| | - Cecília M P Rodrigues
- Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal
| | - Susana Solá
- Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal
| | - Maria M M Santos
- Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal
| |
Collapse
|
17
|
Lotfy G, El Ashry ESH, Said MM, El Tamany ES, Abdel Aziz YM, Al-Dhfyan A, Al-Majid AM, Barakat A. Regio- and stereoselective synthesis of new spirooxindoles via 1,3-dipolar cycloaddition reaction: Anticancer and molecular docking studies. JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY 2018; 180:98-108. [DOI: 10.1016/j.jphotobiol.2018.01.026] [Citation(s) in RCA: 27] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/11/2017] [Revised: 12/30/2017] [Accepted: 01/24/2018] [Indexed: 11/28/2022]
|